Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Willis expands CyMax cyber insurance for SMEs in EMEA with broader access and faster coverage.

Market News
01 Jul 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Willis Towers Watson has expanded its CyMax Facility, a cyber insurance product tailored for SMEs and middle market companies in the EMEA region. The updated facility offers broader insurer participation, higher coverage limits, and a simplified application process, making it easier and faster for eligible companies to secure cyber protection. It covers a wide range of cyber risks including data breaches, ransomware, and supply chain disruptions, with added support for crisis management and incident response. This expansion aims to enhance cyber resilience for smaller businesses facing increasingly complex cyber threats.

More News

Frequency Synthesizer Market to reach $5.31B by 2035 driven by 5G, automotive radar, and defense tech growth

Frequency Synthesizer Market to reach $5.31B by 2035 driven by 5G, automotive radar, and defense tech growth

The global Frequency Synthesizer Market, valued at $2.42 billion in 2025, is projected to grow to $5.31 billion by 2035 at a CAGR of 7.23%. Growth is fueled by expanding 5G infrastructure, automotive radar deployment, and rising demand in aerospace, ...

Market News
Bullish
51 minutes ago
Societe Generale launches new Senior Preferred bond issuance maturing in 2028 and 2031.

Societe Generale launches new Senior Preferred bond issuance maturing in 2028 and 2031.

Societe Generale has announced the launch of a new Senior Preferred bond issuance with two tranches maturing in July 2028 and July 2031. This issuance is part of the bank's 2026 long-term funding program, aiming to support its financial stability and...

Company Fundamentals
Neutral
1 hour ago
Abivax temporarily suspends trading on Euronext Paris amid US share offering process

Abivax temporarily suspends trading on Euronext Paris amid US share offering process

Abivax, a clinical-stage biotech company, has temporarily suspended trading of its ordinary shares on Euronext Paris starting July 1, 2026, at 9:00 CEST. This suspension is at Abivax's request to facilitate the confirmation of allocations and final t...

Market News
Neutral
2 hours ago
Sanofi publishes Q2 2026 financial memo ahead of July 30 earnings release

Sanofi publishes Q2 2026 financial memo ahead of July 30 earnings release

Sanofi has released its Q2 2026 aide-mémoire document on its investor website to assist financial modeling for the upcoming quarterly results. This memo includes details on non-comparable items, currency impacts, and share count. The full Q2 2026 ear...

Company Fundamentals
Neutral
2 hours ago
Global human fibrinogen concentrate market to reach $2.78B by 2035 with 11.3% CAGR, driven by rising bleeding disorders and surgeries.

Global human fibrinogen concentrate market to reach $2.78B by 2035 with 11.3% CAGR, driven by rising bleeding disorders and surgeries.

The global human fibrinogen concentrate market is projected to grow from approximately $0.95 billion in 2025 to $2.78 billion by 2035, at a compound annual growth rate (CAGR) of 11.3%. This growth is fueled by increasing cases of bleeding disorders, ...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App